- Home
- BSX vs BME Comparison
BSX vs BME Comparison
Compare BSX & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- BME
- Stock Information
- Founded
- BSX 1979
- BME 2005
- Country
- BSX United States
- BME United States
- Employees
- BSX N/A
- BME N/A
- Industry
- BSX Medical/Dental Instruments
- BME Trusts Except Educational Religious and Charitable
- Sector
- BSX Health Care
- BME Finance
- Exchange
- BSX Nasdaq
- BME Nasdaq
- Market Cap
- BSX 157.6B
- BME 474.7M
- IPO Year
- BSX 1992
- BME N/A
- Fundamental
- Price
- BSX $98.50
- BME $36.41
- Analyst Decision
- BSX Strong Buy
- BME
- Analyst Count
- BSX 22
- BME 0
- Target Price
- BSX $118.91
- BME N/A
- AVG Volume (30 Days)
- BSX 7.8M
- BME 34.0K
- Earning Date
- BSX 10-22-2025
- BME 01-01-0001
- Dividend Yield
- BSX N/A
- BME 6.26%
- EPS Growth
- BSX 36.90
- BME N/A
- EPS
- BSX 1.68
- BME 1.44
- Revenue
- BSX $18,494,000,000.00
- BME N/A
- Revenue This Year
- BSX $19.75
- BME N/A
- Revenue Next Year
- BSX $11.03
- BME N/A
- P/E Ratio
- BSX $58.59
- BME $28.37
- Revenue Growth
- BSX 21.44
- BME N/A
- 52 Week Low
- BSX $80.64
- BME $35.53
- 52 Week High
- BSX $109.50
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- BSX 28.49
- BME 44.93
- Support Level
- BSX $104.24
- BME $37.03
- Resistance Level
- BSX $109.50
- BME $37.58
- Average True Range (ATR)
- BSX 2.11
- BME 0.32
- MACD
- BSX -1.00
- BME -0.09
- Stochastic Oscillator
- BSX 8.52
- BME 12.31
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.